Amalgamated Financial’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$138K Buy
+2,542
New +$138K ﹤0.01% 2034